1. Home
  2. DVA vs TTEK Comparison

DVA vs TTEK Comparison

Compare DVA & TTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • TTEK
  • Stock Information
  • Founded
  • DVA 1994
  • TTEK 1966
  • Country
  • DVA United States
  • TTEK United States
  • Employees
  • DVA N/A
  • TTEK N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • TTEK Military/Government/Technical
  • Sector
  • DVA Health Care
  • TTEK Consumer Discretionary
  • Exchange
  • DVA Nasdaq
  • TTEK Nasdaq
  • Market Cap
  • DVA 10.9B
  • TTEK 9.2B
  • IPO Year
  • DVA 1995
  • TTEK 1991
  • Fundamental
  • Price
  • DVA $136.18
  • TTEK $34.94
  • Analyst Decision
  • DVA Hold
  • TTEK Buy
  • Analyst Count
  • DVA 4
  • TTEK 5
  • Target Price
  • DVA $157.00
  • TTEK $40.00
  • AVG Volume (30 Days)
  • DVA 828.5K
  • TTEK 2.7M
  • Earning Date
  • DVA 05-12-2025
  • TTEK 05-07-2025
  • Dividend Yield
  • DVA N/A
  • TTEK 0.74%
  • EPS Growth
  • DVA 14.90
  • TTEK N/A
  • EPS
  • DVA 10.11
  • TTEK 0.69
  • Revenue
  • DVA $12,968,524,000.00
  • TTEK $4,555,101,000.00
  • Revenue This Year
  • DVA $6.00
  • TTEK $8.15
  • Revenue Next Year
  • DVA $3.66
  • TTEK N/A
  • P/E Ratio
  • DVA $13.48
  • TTEK $50.55
  • Revenue Growth
  • DVA 5.11
  • TTEK 10.76
  • 52 Week Low
  • DVA $131.76
  • TTEK $27.27
  • 52 Week High
  • DVA $179.60
  • TTEK $51.20
  • Technical
  • Relative Strength Index (RSI)
  • DVA 37.73
  • TTEK 60.04
  • Support Level
  • DVA $136.50
  • TTEK $34.78
  • Resistance Level
  • DVA $140.42
  • TTEK $36.37
  • Average True Range (ATR)
  • DVA 3.66
  • TTEK 0.76
  • MACD
  • DVA -0.59
  • TTEK -0.11
  • Stochastic Oscillator
  • DVA 11.71
  • TTEK 25.13

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

About TTEK Tetra Tech Inc.

Tetra Tech Inc provides consulting and engineering services for environmental, infrastructure, resource management, energy, and international development markets. It specializes in providing water-related services for public and private clients. It designs infrastructure, facilities, and other structures with complex plans and resource management. Tetra Tech has two reportable segments. Its Government Services Group (GSG) segment includes activities with U.S. government clients (federal, state and local) and activities with development agencies world-wide. Commercial/International Services Group (CIG) segment, which derives maximum revenue, includes activities with U.S. commercial clients and international clients other than development agencies.

Share on Social Networks: